Where is the 13-valent pneumococcal vaccine administered?

Apr 18, 2023 Source: Cainiu Health

Dr. Guo Xiheng

Introduction

The 13-valent pneumococcal vaccine refers to the 13-valent pneumococcal polysaccharide conjugate vaccine, which is generally administered into the deltoid muscle of the upper arm. For younger individuals, it may also be injected into the anterolateral thigh. The 13-valent pneumococcal polysaccharide conjugate vaccine is an inactivated vaccine primarily used to prevent diseases such as pneumonia and upper respiratory tract infections caused by Streptococcus pneumoniae infection.

The 13-valent pneumococcal vaccine refers to the 13-valent pneumococcal polysaccharide conjugate vaccine. It is generally administered into the deltoid muscle of the upper arm. However, for younger recipients, it may also be injected into the anterolateral thigh.

The 13-valent pneumococcal polysaccharide conjugate vaccine is an inactivated vaccine primarily used to prevent diseases caused by Streptococcus pneumoniae infection, such as pneumonia and upper respiratory tract infections. The main target population is infants and children aged 6 weeks to 5 years. The vaccine is typically injected into the deltoid muscle of the upper arm because this site is close to lymphatic tissue, allowing rapid activation of the immune system. Additionally, since the vaccine components are not absorbed through the stomach or intestines, fewer drug components enter the bloodstream, resulting in a lower probability of side effects. However, in very young children whose bodies have not fully developed, the thigh area contains more fatty tissue, making it less likely for the needle to hit nerve structures during injection, thus offering a safer option.

After receiving the 13-valent pneumococcal polysaccharide conjugate vaccine, a small puncture site will remain on the skin. Therefore, it is important to strengthen personal care afterward, maintain good skin hygiene, and avoid bacterial invasion that could lead to wound infection.

View All

Who is suitable for the 23-valent pneumococcal vaccine?

The 23-valent pneumococcal vaccine, commonly known as the 23-valent pneumonia vaccine, is suitable for individuals aged 2 years and older who are susceptible to pneumococcal infection. It is also recommended for those with chronic liver disease, alcohol intoxication, or impaired immune function. Generally, a single dose is sufficient; however, high-risk individuals for pneumococcal infection or those whose antibody levels decline rapidly after the initial vaccination may receive a second dose.

View Full Answer

Can people with pulmonary bullae receive the pneumonia vaccine?

Pneumothorax patients are not always eligible for pneumococcal vaccination. If the condition is relatively stable and there are no symptoms such as cough, chest tightness, chest pain, or shortness of breath, vaccination is generally acceptable. However, if the pneumothorax is in an acute phase, prompt treatment is usually required, and vaccination should be postponed until the condition stabilizes to avoid worsening the illness.

View Full Answer

Is it effective to get a pneumonia vaccine?

Injecting the pneumonia vaccine is generally effective, but it is not useful if the patient already has pneumonia. Pneumonia vaccines are usually inactivated vaccines; after vaccination, they stimulate the body to produce specific antibodies, thereby preventing pneumonia. If exposed to the relevant pathogens again, the body can quickly mount an immune response to eliminate the disease-causing bacteria.

View Full Answer

How many doses of pneumonia vaccine do adults need?

Adults only need one dose of the pneumococcal vaccine. Pneumococcal vaccines are mainly divided into 7-valent, 13-valent, and 23-valent vaccines. The 23-valent vaccine is primarily used to prevent pneumonia caused by Streptococcus pneumoniae infection. Compared to other vaccines, it is more widely used and suitable for adults and children over two years of age. Under normal circumstances, adults require only a single dose.